While the health-care sector broadly continues to search for direction, drug stocks have been the clear leaders — and Merck stands out as one of the strongest performers in the group. Over the past few months, the stock has demonstrated a notable ability to leverage multi-week consolidation phases into clean breakouts and sustained advances. Since February, Merck has been quietly digesting its latest move, and it’s worth paying close attention to the structure taking shape. The developing base now resembles a potential inverse head-and-shoulders pattern — one of the more reliable bottoming formations in technical analysis. As with any pattern of this type, patience is key. Some additional consolidation beneath the noted resistance…
